Enovis SG&A Expenses 2010-2024 | ENOV

Enovis sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Enovis Annual SG&A Expenses
(Millions of US $)
2023 $830
2022 $773
2021 $666
2020 $515
2019 $1,132
2018 $549
2017 $501
2016 $697
2015 $748
2014 $1,011
2013 $864
2012 $908
2011 $163
2010 $134
2009 $113
Enovis Quarterly SG&A Expenses
(Millions of US $)
2024-09-30 $250
2024-06-30 $264
2024-03-31 $256
2023-12-31 $211
2023-09-30 $204
2023-06-30 $208
2023-03-31 $207
2022-12-31 $209
2022-09-30 $182
2022-06-30 $194
2022-03-31 $188
2021-12-31 $-6
2021-09-30 $168
2021-06-30 $198
2021-03-31 $306
2020-12-31 $-291
2020-09-30 $278
2020-06-30 $236
2020-03-31 $292
2019-12-31 $286
2019-09-30 $291
2019-06-30 $308
2019-03-31 $248
2018-12-31 $83
2018-09-30 $130
2018-06-30 $136
2018-03-31 $201
2017-12-31 $-33
2017-09-30 $182
2017-06-30 $177
2017-03-31 $175
2016-12-31 $101
2016-09-30 $168
2016-06-30 $214
2016-03-31 $214
2015-12-31 $75
2015-09-30 $237
2015-06-30 $223
2015-03-31 $213
2014-12-31 $255
2014-09-30 $245
2014-06-30 $279
2014-03-31 $232
2013-12-31 $220
2013-09-30 $209
2013-06-30 $222
2013-03-31 $214
2012-12-31 $247
2012-09-30 $217
2012-06-30 $232
2012-03-31 $212
2011-12-31 $39
2011-09-30 $41
2011-06-30 $44
2011-03-31 $38
2010-12-31 $46
2010-09-30 $30
2010-06-30 $28
2010-03-31 $29
2009-12-31 $27
2009-09-30 $28
2009-06-30 $29
2009-03-31 $30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.529B $1.707B
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00